6533b85dfe1ef96bd12bea74

RESEARCH PRODUCT

Prevention of long-term IgE antibody production by gene gun-mediated DNA vaccination.

subject

description

Background Vaccination with allergen-encoding DNA represents a promising approach for the treatment of allergic diseases. Objective In a mouse model of type I allergy, we analyzed the ability of biolistic transfection to inhibit antigen-specific IgE production and to modulate T H 2 responses. Methods BALB/c mice were vaccinated by means of gene gun–mediated DNA immunization with plasmid vector pCMV-βGal, encoding β-galactosidase as a model allergen. Subsequently, mice were immunized by means of repeated intraperitoneal injection of β-galactosidase adsorbed to the adjuvant aluminum hydroxide. Development of IgE, IgG1, and IgG2a antibody titers during the course of immunization was followed, and anaphylactic potential of sera was determined by using RBL-2H3 degranulation assay. Spleen cells of vaccinated mice and unvaccinated control animals were stimulated in vitro to analyze cytokine production and induction of CD8 + effector T cells. Results Gene gun–mediated DNA immunization with pCMV-βGal very efficiently prevented IgE antibody production on a long-term basis. Concomitantly, IgG1 antibody levels in vaccinated mice were strongly reduced, whereas IgG2a antibody production was increased. Analysis of cytokine profiles indicated immune deviation from a T H 2-biased response in control mice toward a mixed T H 1/T H 2 response in vaccinated mice. In addition, substantial numbers of IFN-γ–producing CD8 + effector T cells were found in vaccinated mice. Conclusion Gene gun–mediated DNA vaccination prevents the induction of long-lasting IgE antibody production.